Boston Scientific Reports Death From Defibrillator Glitch

Law360, New York (April 25, 2012, 1:54 PM EDT) -- Boston Scientific Corp. confirmed Wednesday that a patient has died because of a problem with a part used with its implantable Cognis and Teligen defibrillators, but said such malfunctions have been rare.

The Cognis and Teligen defibrillators are small implantable devices that use electrical pulses or shocks to help treat irregular heartbeats and heart failures.

According to Boston Scientific, an electrical component called a transformer used with Cognis and Teligen defibrillators has exhibited a pattern of malfunction that has occurred in 1 out of every 8,900...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.